
11 - 50 employees
Founded 2017
🧬 Biotechnology
🏥 Healthcare
💊 Pharmaceuticals
💰 $40M Series A on 2022-08
Biotechnology • Healthcare • Pharmaceuticals
3T Biosciences is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patient populations. By leveraging the power of the immune system to recognize, target, and destroy cancer cells, 3T's technology is advancing the development of next-generation therapies that have the potential to be safer, more effective, and even curative for difficult-to-treat cancers.
Selected: 🆕 Date Added.
🔥 15 hours ago
Bioinformatics Scientist developing reproducible analyses for targeted NGS oncology assays. Supporting genomic data interpretation, assay optimization, and cross-functional development.
🇺🇸 United States – Remote
💵 $90k - $120k / year
💰 $40M Series A on 2022-08
⏰ Full Time
🟡 Mid-level
🟠 Senior
✨ Scientist
👻 Ghost score 0%